Argitalpenak (59) ISABEL MARÍA PÉREZ FLORES argitalpenak

2024

  1. Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch

    Transplantation, Vol. 108, Núm. 3, pp. 787-801

  2. Incidence of adverse events of the Covid-19 vaccine in a population of kidney transplant recipients

    Enfermeria Nefrologica, Vol. 27, Núm. 2, pp. 119-125

2023

  1. Development of an Information Guideline for Kidney Transplant Recipients in a Clinical Trial: Protocol for a Modified Delphi Method

    JMIR Research Protocols, Vol. 12, Núm. 1

  2. Genome-wide association study biomarkers in T-cell mediated rejection: selective effect according to the Banff classification

    Journal of Nephrology, Vol. 36, Núm. 3, pp. 809-815

  3. Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry

    Nefrologia, Vol. 43, Núm. 4, pp. 442-451

  4. Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients

    Frontiers in Immunology, Vol. 14

2022

  1. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients

    Transplantation, Vol. 106, Núm. 7, pp. 1430-1439

  2. Clinical Effectiveness of SARS-CoV-2 Vaccination in Renal Transplant Recipients. Antibody Levels Impact in Pneumonia and Death

    Transplantation, Vol. 106, Núm. 11, pp. e476-e487

  3. Live donor kidney transplantation. Situation analysis and roadmap

    Nefrologia, Vol. 42, Núm. 1, pp. 85-93

2021

  1. Association of Polymorphisms in T-Cell Activation Costimulatory/Inhibitory Signal Genes With Allograft Kidney Rejection Risk

    Frontiers in Immunology, Vol. 12

  2. Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a spanish multicenter cohort

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 5

  3. Hemophagocytic syndrome triggered by donor-transmitted toxoplasmosis as a complication in same-donor recipients of renal transplantation: Case report and review of the literature

    Transplant Infectious Disease, Vol. 23, Núm. 6

  4. Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: Analysis of the Spanish Registry

    American Journal of Transplantation, Vol. 21, Núm. 7, pp. 2573-2582

2020

  1. Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients—Results of a Spanish multicenter cohort

    American Journal of Transplantation, Vol. 20, Núm. 2, pp. 451-462

  2. The Interferon-Gamma +874 A/T Polymorphism Is Not Associated With CMV Infection After Kidney Transplantation

    Frontiers in Immunology, Vol. 10

  3. Use of tocilizumab in kidney transplant recipients with COVID-19

    American Journal of Transplantation, Vol. 20, Núm. 11, pp. 3182-3190

2019

  1. De novo IgA nephropathy in a renal allograft

    Experimental and Clinical Transplantation, Vol. 17, Núm. 4, pp. 550-553

  2. Impacts of Interleukin-18 Polymorphisms on the Incidence of Delayed-Onset Cytomegalovirus Infection in a Cohort of Kidney Transplant Recipients

    Open Forum Infectious Diseases, Vol. 6, Núm. 9

  3. Kidney transplant from controlled donors following circulatory death: Results from the GEODAS-3 multicentre study

    Nefrologia, Vol. 39, Núm. 2, pp. 151-159

  4. Uncontrolled donation after circulatory death: A cohort study of data from a long-standing deceased-donor kidney transplantation program

    American Journal of Transplantation, Vol. 19, Núm. 6, pp. 1693-1707